Evaluation of chitoligosaccharides effect upon probiotic bacteria

Area of Science:

• Microbiology
• Biochemistry
• Food Science

Background:

• Chitooligosaccharides (COS) are derived from chitin and are known for potential health benefits.
• Probiotics like Bifidobacterium and Lactobacillus are crucial for gut health.
• Understanding the interaction between COS and probiotics is important for functional food development.

Purpose of the Study:

• To evaluate the antibacterial effects and prebiotic potential of chitooligosaccharides (COS).
• To investigate the impact of COS on specific probiotic strains: Bifidobacterium animalis Bb12, Bifidobacterium animalis Bo, and Lactobacillus acidophilus Ki.

Main Methods:

• Determination of minimum inhibitory concentrations (MIC) and minimum lethal concentrations (MLC).
• Assessment of growth curves to evaluate prebiotic potential.
• Atomic force microscopy (AFM) for high-resolution imaging of bacterial cell morphology.

Main Results:

• COS did not stimulate the growth of the tested Bifidobacterium and Lactobacillus strains.
• The bacteria were unable to utilize COS as a primary carbon source.
• Atomic force microscopy revealed that COS did not directly damage bacterial structures.
• At inhibitory/bactericidal concentrations, COS appeared to coat the bacteria, potentially impeding nutrient uptake.

Conclusions:

• Chitooligosaccharides (COS) do not possess prebiotic potential for Bifidobacterium animalis and Lactobacillus acidophilus.
• The antibacterial effect of COS at higher concentrations is likely due to physical obstruction of nutrient absorption rather than direct cell damage.